These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1763455)

  • 1. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
    Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
    Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of thymic preparations on the result of experimental infection with Taenia crassiceps (Zeder, 1800) in ICR mice.
    Hermánek J; Prokopic J
    Folia Parasitol (Praha); 1989; 36(4):331-40. PubMed ID: 2488049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of testosterone preparations in complex therapy of severe herpetic keratitis in male patients].
    Zaĭnutdinova GKh; Mal'khanov VB
    Vestn Oftalmol; 2004; 120(3):24-6. PubMed ID: 15216768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 7. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The electrophoretic mobility of peripheral blood lymphocytes in patients with tuberculosis of the lungs].
    Skvortsova RG; Nikitina OI
    Probl Tuberk; 1990; (5):11-4. PubMed ID: 2388887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary immunodeficiency and its correction with thymus preparations in patients with postabortion endometritis].
    Franchuk AE; Benzar ZT
    Akush Ginekol (Mosk); 1990 Sep; (9):40-3. PubMed ID: 2278306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Probl Tuberk; 1991; (12):52-4. PubMed ID: 1803376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 14. [The efficacy of immunomodulating preparations in treating patients with chronic cholestatic liver diseases].
    Radchenko VG; Mitrofanova TI; Serebriakova VI; Vinogradova GL
    Lik Sprava; 1992; (11-12):38-41. PubMed ID: 1292217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice.
    Beuth J; Schierholz JM; Ko HL; Braun JM
    In Vivo; 2001; 15(5):403-6. PubMed ID: 11695237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of T-activin in viral myocarditis in animal experiments].
    Kipshidze NN; Dzhaparidze MM; Bulusashvili RV; Khuchua AV; Zbiadadze NA
    Biull Eksp Biol Med; 1988 Jun; 105(6):705-7. PubMed ID: 3260519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thymus insufficiency and its correction in patients with recurrent ophthalmic herpes].
    Petrov RV; Maĭchuk IuF; Arion VIa; Mikuli SG
    Vestn Oftalmol; 1988; 104(6):39-41. PubMed ID: 3242204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
    Arion VIa; Bekman EM; Tiurin NA; Mazurina NA; Filimonova AV
    Biull Eksp Biol Med; 1994 Nov; 118(11):496-8. PubMed ID: 7888649
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention and treatment of postoperative complications of hepatic echinococcosis].
    Akhmedov RM; Ochilov UB; Mirkhodzhaev IA; Komilov TS; Makliev BIu
    Med Parazitol (Mosk); 2003; (2):18-21. PubMed ID: 12886586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].
    Shilov VA; Shirinskiĭ VS
    Klin Med (Mosk); 1995; 73(4):88-90. PubMed ID: 7474838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.